Alzheimer's Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People whose memory and thinking test scores fall within a specific range, suggesting mild or early cognitive changes (based on two standard assessments called the MMSE and CDR-SB)
• People who have had testing confirming the presence of amyloid plaques in the brain, either through a brain scan or a fluid sample from around the spine
• People who have completed genetic testing for the APOE gene
• People who are willing to receive the study drug, Lecanemab

Who may not be able to join:

• People who are unable to tolerate MRI scans
• People whose MRI results show certain bleeding-related changes in the brain, such as more than 4 small bleeds, iron deposits on the brain surface, a history of major brain bleeding, or abnormal blood vessel structures
• People who take blood-thinning or anti-clotting medications, have a condition that affects blood clotting, or have any other condition that raises the risk of bleeding in the brain or nervous system
• People with unstable physical health conditions, unstable mental health conditions, or people who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.